Severe Mycoplasma Pneumoniae Infection in Children Admitted to Pediatric Intensive Care
- 1 December 2018
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 37 (12) , e336-e338
Abstract
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia and may cause life-threatening disease in children. We identified 30 (0.3%) confirmed M. pneumoniae cases by clinical and laboratory criteria in 11,526 pediatric intensive care unit admissions. Outcomes were comparable to patients admitted with other infections (n=3005; P > 0.1). Our findings indicate that empiric antimicrobial coverage for M. pneumoniae infection in pediatric intensive care unit is rarely needed.Keywords
This publication has 8 references indexed in Scilit:
- Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With PneumoniaJAMA Pediatrics, 2017
- Impact of Viral Respiratory Pathogens on Outcomes After Pediatric Cardiac SurgeryPediatric Critical Care Medicine, 2017
- Community-Acquired Pneumonia Requiring Hospitalization among U.S. ChildrenNew England Journal of Medicine, 2015
- Typical or atypical pneumonia and severe acute respiratory symptoms in PICUThe Clinical Respiratory Journal, 2014
- Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis BronchiectasisJAMA, 2013
- Rising Rates of Macrolide-Resistant Mycoplasma pneumoniae in the Central United StatesThe Pediatric Infectious Disease Journal, 2012
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Epidemiology, clinical manifestations, pathogenesis and laboratory detection ofMycoplasma pneumoniaeinfections: Figure 1FEMS Microbiology Reviews, 2008